about
Endothelial dysfunction in diabetes mellitus: role in cardiovascular disease.Systolic and diastolic heart failure--diagnostic and therapeutic dilemmas.Chronic heart failure as a metabolic disorder.Polypharmacy (or polytherapy) in the treatment of heart failure.Should patients with chronic heart failure be treated with "statins"?Prognosis of patients with heart failure compared with common types of cancer.Asymptomatic left ventricular dysfunction: an overlooked part of the continuum of heart failure.The role of invasive electrophysiology in the management of patients with chronic heart failure.Does growth hormone play a role in chronic heart failure?Novel mechanisms of sympatho-excitation in chronic heart failure.The impact of obesity on survival in patients with heart failure.Who and how to treat with non-surgical myocardial reduction therapy in hypertrophic cardiomyopathy: long-term outcomes.Antiarrhythmic therapy in heart failure.Mechanical circulatory support devices--state of the art.The development of new medical treatments for acute decompensated heart failure.Renal function as a predictor of prognosis in chronic heart failure.The importance of tumor necrosis factor and lipoproteins in the pathogenesis of chronic heart failure.Biventricular pacing in patients with heart failure and intraventricular conduction delay.Vasopeptidase inhibitors: potential role in the treatment of heart failure.The cytokine network in heart failure: pathogenetic importance and potential therapeutic targets.Diabetes and dyslipidemia.Experimental options in the treatment of heart failure: the role of cytokine antagonism.Ischemic versus non-ischemic heart failure: should the etiology be determined?Chemosensitivity in chronic heart failure.Constrictive pericarditis and restrictive cardiomyopathy: similarities and differences.Current insights into the pathogenesis, diagnosis and therapy of inflammatory cardiomyopathy.Anemia in chronic congestive heart failure: frequency, prognosis, and treatment.The emerging role of brain natriuretic peptide in the management of acute and chronic heart failure in outpatients.Back to the future?Screening for left ventricular systolic dysfunction: the use of B-type natriuretic peptide.Beta-blocker use in patients with congestive heart failure and concomitant obstructive airway disease: moving from myth to evidence-based practice.Left ventricular remodeling: pathophysiology and treatment.Optimizing the clinical exercise test: a commentary on the exercise protocol.Statins: a treatment option for chronic heart failure?BNP in the diagnosis and risk stratification of heart failure.Chronic heart failure and multiple micronutrient supplementation: realistic hope or idealistic conjecture?Aging and heart failure--similar syndromes of exercise intolerance? Implications for exercise-based interventions.Anti-inflammatory trials in chronic heart failure.Glycemic control and treatment patterns in patients with heart failure.Treatment of hypertension in patients with congestive cardiac failure.
P1433
Q35084599-F28FE48C-E5C9-447B-9CE1-7DBECCCA3D86Q35084603-CCD1C4B0-610F-4321-9FDA-32EF42CA5DC7Q35084608-19FA0130-8459-4654-9760-198FBD32B5C9Q35084617-9995B9A2-F356-4264-973B-21C802897045Q35084619-0B90F635-3163-4822-803C-72A89DA158FCQ35084623-3734C083-D93B-479E-9C37-0A182470771AQ35084626-0C8626CC-8024-482C-8BA5-9662CB5FD6ECQ35084629-3BEE45FC-FDA3-40E3-B9DC-26DBB99674F0Q35084631-D6196F24-23A7-4F96-A0C7-6216A61CF592Q35084635-41945C4F-63E3-44C6-931D-438BC8E54B47Q35084638-32ED5853-1E49-43C3-9AA2-D924B3DA1DE6Q35084641-7BDF5C0B-B43E-4DE8-BFF3-5B43E7BE945AQ35084645-C55B08C0-35CF-4249-9A53-A9CDAC2724A0Q35084649-F0C72DE4-9C84-4044-A0BA-AE8A403C2550Q35084652-BA4A0C78-8B76-4FC9-9330-2F6CD8DEDB89Q35084655-54F39C45-C3FB-4909-8BF4-C9FF8A991D31Q35084659-948F489A-45BB-44D3-AE6F-974257E9F1DFQ35084661-D601E080-1517-430D-A869-28271161DCD0Q35084665-359BAD25-F1FE-4F31-A276-E6389F553EF1Q35084669-C4D3B287-F4A6-431B-9363-EF480CF9CCF4Q35084672-785627EF-DFD7-46CE-919E-3539222CE137Q35084675-D6E24DF3-027D-4B1D-B021-37048980BE9AQ35084678-5E988253-2E25-4551-9262-0A0261AD7695Q35084682-546AC396-3688-40FB-A442-73971B7BDBEFQ35112624-BD34D344-B179-435C-BC7C-AFB93AE895C5Q35112627-FAD03886-918C-4981-A711-2DD72C304BD1Q35155239-CE33CF14-B5AE-4CEF-A98C-C64CFD939E27Q35155248-CCF5067A-FFC3-4AC8-8CB2-CE75D0914C63Q35168197-8120B03E-EF99-4797-B732-3649F3970AA7Q35629612-DE176A6C-A28A-4468-96E1-D9D5C3469D0DQ35629618-A766A37E-D0DA-491C-9F17-093CBC8FBD80Q35629624-0F193326-A960-4A6D-83B0-00BF9B319190Q36072821-801C2299-A710-4A00-8DE7-E2B16C376B37Q36072825-D1EAAC9D-9A76-4330-A896-E8B9D37A3761Q36290585-F19CB26C-73E9-4605-B3C6-23E5A65D012EQ36290590-94CEB3EF-BB04-4AE9-9A1A-90A962DE6451Q36290595-9D1BABC0-C0A2-4336-811E-E9D6A5E9D750Q36425459-69D159DA-1A6A-4640-AA55-721FAFB1A860Q36425464-32C7FB0B-955E-4B6D-9807-F7172FBFC0F9Q36525824-C420B836-2CEF-47A4-A285-DBADE3EA7E5D
P1433
description
czasopismo naukowe
@pl
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
name
Heart failure monitor
@ast
Heart failure monitor
@en
Heart failure monitor
@es
Heart failure monitor
@nl
type
label
Heart failure monitor
@ast
Heart failure monitor
@en
Heart failure monitor
@es
Heart failure monitor
@nl
altLabel
Heart Fail Monit
@en
prefLabel
Heart failure monitor
@ast
Heart failure monitor
@en
Heart failure monitor
@es
Heart failure monitor
@nl
P1055
P1156
P1476
Heart failure monitor
@en